Literature DB >> 10190535

Effect of hormone replacement therapy on left ventricular hypertrophy.

W K Lim1, B Wren, N Jepson, S Roy, G Caplan.   

Abstract

The mechanisms behind the reduction in cardiovascular morbidity and mortality in postmenopausal women receiving hormone replacement therapy are not fully understood. In this case-control study, we report a statistically significant lower left ventricular mass in a group of elderly women who were receiving hormone replacement therapy for >10 years than in age-matched controls.

Entities:  

Mesh:

Year:  1999        PMID: 10190535     DOI: 10.1016/s0002-9149(99)00029-6

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  15 in total

1.  Sex hormone levels and change in left ventricular structure among men and post-menopausal women: The Multi-Ethnic Study of Atherosclerosis (MESA).

Authors:  Vinita Subramanya; Di Zhao; Pamela Ouyang; Joao A Lima; Dhananjay Vaidya; Chiadi E Ndumele; David A Bluemke; Sanjiv J Shah; Eliseo Guallar; Chike C Nwabuo; Matthew A Allison; Susan R Heckbert; Wendy S Post; Erin D Michos
Journal:  Maturitas       Date:  2017-11-09       Impact factor: 4.342

Review 2.  Exercise-induced myocardial ischaemia in women: factors affecting prevalence.

Authors:  J Goodman; L Kirwan
Journal:  Sports Med       Date:  2001       Impact factor: 11.136

3.  17 beta-estradiol attenuates pressure overload-induced myocardial hypertrophy through regulating caveolin-3 protein in ovariectomized female rats.

Authors:  Yu-Hong Cui; Zhi Tan; Xiao-Dong Fu; Qiu-Ling Xiang; Jin-Wen Xu; Ting-Huai Wang
Journal:  Mol Biol Rep       Date:  2010-12-18       Impact factor: 2.316

4.  Estrogen inhibits cardiomyocyte hypertrophy in vitro. Antagonism of calcineurin-related hypertrophy through induction of MCIP1.

Authors:  Ali Pedram; Mahnaz Razandi; Mark Aitkenhead; Ellis R Levin
Journal:  J Biol Chem       Date:  2005-05-16       Impact factor: 5.157

Review 5.  Sex Differences in Molecular Mechanisms of Cardiovascular Aging.

Authors:  Vanessa Dela Justina; Jéssica S G Miguez; Fernanda Priviero; Jennifer C Sullivan; Fernanda R Giachini; R Clinton Webb
Journal:  Front Aging       Date:  2021-09-10

Review 6.  Sex related differences in the pathogenesis of organ fibrosis.

Authors:  Alejandra Garate-Carrillo; Julisa Gonzalez; Guillermo Ceballos; Israel Ramirez-Sanchez; Francisco Villarreal
Journal:  Transl Res       Date:  2020-03-16       Impact factor: 7.012

7.  Estrogen inhibits cardiac hypertrophy: role of estrogen receptor-beta to inhibit calcineurin.

Authors:  Ali Pedram; Mahnaz Razandi; Dennis Lubahn; Jinghua Liu; Mani Vannan; Ellis R Levin
Journal:  Endocrinology       Date:  2008-03-27       Impact factor: 4.736

8.  ERβ selective agonist inhibits angiotensin-induced cardiovascular pathology in female mice.

Authors:  Ali Pedram; Mahnaz Razandi; Kenneth S Korach; Ramesh Narayanan; James T Dalton; Ellis R Levin
Journal:  Endocrinology       Date:  2013-08-22       Impact factor: 4.736

9.  Estrogen regulates histone deacetylases to prevent cardiac hypertrophy.

Authors:  Ali Pedram; Mahnaz Razandi; Ramesh Narayanan; James T Dalton; Timothy A McKinsey; Ellis R Levin
Journal:  Mol Biol Cell       Date:  2013-10-23       Impact factor: 4.138

Review 10.  Influence of sex hormones and phytoestrogens on heart disease in men and women.

Authors:  Poornima Bhupathy; Christopher Dean Haines; Leslie Anne Leinwand
Journal:  Womens Health (Lond)       Date:  2010-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.